3SOF

03:01 ET Conolog announces P.T.R equipment selected for two windmill electric generator farms in North America (CNLG) 1.20 +0.20:Co announces its P.T.R equipment has been selected to protect two windmill electric generator farms' transmission lines that connect to the local power grid


Buy confirmed

The volume indicates accumulation, open mind

08:01 ET Ciena: Progress Telecom selects Ciena for next gen network (CIEN) 3.59 0.17:Progress Telecom selected CIEN's CN 4200 FlexSelect Advanced Services Platform for 10G DWDM metro and regional transport and CN 3600 Intelligent Optical Multiservice Switch for international gateway and SONET/SDH applications. Progress Telecom operates one of the largest regional networks in the U.S. spanning 8,254 route-miles of fiber, 29 metro networks and 10 states from FL to NY. The service provider delivers a variety of broadband services to its carrier, ISP and large enterprise customers, including SONET/SDH conversion, private line, wavelength, Ethernet and Internet Protocol services. Progress Telecom's nearly 200 points of presence range from carrier hotels and undersea cable landing stations to wireless network towers and end-user locations, putting a wide variety of operating requirements on its network equipment

09:01 ET AVI BioPharma reports confirmation of efficacy against Influenza Strains (AVII) 5.89 :Co announces confirmation from three independent laboratories of NEUGENE antisense efficacy in preclinical experiments against multiple strains of influenza, including avian influenza strain H5N1. Dr. P. Puthavathana at Mahidol University in Bangkok, Thailand, confirmed NEUGENE antisense efficacy against an H5N1 viral isolate in her assay system. Dr. Darwyn Kobasa at the Public Health Agency of Canada in Winnipeg, Manitoba, completed an initial dose-response study in cell culture demonstrating NEUGENE efficacy against both the H1N1 and H3N2 strains. "Based on these recent findings and other results from additional studies, AVI now plans to file an Investigative New Drug application with the FDA for the treatment of influenza A virus with NEUGENE antisense drugs..We feel confident in the safety, efficacy and potency of our NEUGENE drugs targeting influenza and plan to move forward into the clinical trial process later this year."

                  1) Xoma Ltd



                  2) Reasons

                      - Volume indicates that is under accumulation
                      - Chart pattern indicates strong potencial



                   3) Chart

         
          1) SmarTire System Inc

          2) Reason behind this pick:
             
              - SMTR is a company in the nano tech world
              - Chart pattern indicate strong up trend
              - volume indicate that the stock is under accumulation

           3) Chart